Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

Pfizer logo

Pfizer

Status

Completed

Conditions

Spondyloarthrosis

Treatments

Drug: Etanercept

Study type

Observational

Funder types

Industry

Identifiers

NCT04507776
B1801414

Details and patient eligibility

About

This study is to evaluate local data in Iraqi patients with Spondyloarthropathies on Enbrel treatment with regards to efficacy and adherence using data from the Baghdad Teaching Hospital (Rheumatology Center)

Enrollment

763 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed SpA patients
  • 18 years of age and older.
  • Did not receive previous other biological treatments.
  • Patients have at least 1 year on Enbrel.

Exclusion criteria

  • Had previously used another biological treatments.
  • Use of etanercept for less than 1 year duration.

Trial design

763 participants in 1 patient group

Patients with spondyloarthropathies
Description:
Patients with spondyloarthrosis that received Etanercept as treatment for disease
Treatment:
Drug: Etanercept

Trial documents
1

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems